Research Article

Upper gut bacterial overgrowth is a potential mechanism for Glucose Malabsorption after Vertical Sleeve Gastrectomy

Matthew E Sharbaugh, Timothy R Shope and Timothy R Koch*

Published: 10/31/2017 | Volume 1 - Issue 1 | Pages: 030-035


In 1955, nutrient malabsorption following upper gut surgery was shown to be related to altered upper gut microbiome. In individuals with abdominal symptoms after Roux-en-Y gastric bypass, we have reported that small intestinal glucose malabsorption is associated with upper gut bacterial overgrowth.We hypothesize that individuals with abdominal symptoms after vertical sleeve gastrectomy have glucose malabsorption associated with upper gut bacterial overgrowth, and to test this hypothesis, bacterial overgrowth and potential glucose malabsorption are examined after sleeve gastrectomy. This is a retrospective study of individuals with medically-complicated obesity who underwent sleeve gastrectomy from 2013 to 2016 with subsequent glucose hydrogen breath testing to evaluate abdominal symptoms. A fasting breath hydrogen or methane of ≥10 PPM or rise of ≥8 PPM ≤45 minutes after oral glucose is bacterial overgrowth, while glucose malabsorption is a second rise of ≥8 PPM at >45 minutes. Seven females (mean age: 48.0 years; mean body mass index at surgery: 45.7 kg/m2) are described. Five subjects (71%) have an early rise in hydrogen or methane, while three (43%) have a second rise in hydrogen or methane >45 minutes after glucose. The mean percent excess weight loss at one year was 40% in three individuals with a second peak and 46% in four subjects without a second peak. After sleeve gastrectomy, subjects have glucose malabsorption associated with the presence of bacterial overgrowth. Completion of a larger prospective study is needed to confirm and expanding upon these findings. Further work should examine the potential effects of bacterial overgrowth on expression of intestinal glucose transporters.

Read Full Article HTML DOI: 10.29328/journal.hodms.1001006 Cite this Article


  1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017; 377: 13-27. Ref.:
  2. American Society for Metabolic and Bariatric Surgery. Estimate of Bariatric Surgery Numbers, 2011-2015. 2016. Ref.:
  3. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, et al. Bariatric Surgery Worldwide 2013. Obesity Surg. 2015; 25: 1822-1832. Ref.:
  4. Halsted JA. Megaloblastic anemia, associated with surgically produced gastrointestinal abnormalities. Calif Med. 1955; 83: 212-217. Ref.:
  5. Lakhani SV, Shah HN, Alexander K, Finelli FC, Kirkpatrick JR, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008; 28: 293-298. Ref.:
  6. Andalib I, Shah H, Bal BS, Shope TR, Finelli FC, et al. Breath hydrogen as a biomarker for glucose malabsorption after Roux-en-Y gastric bypass surgery. Dis Markers. 2015. Ref.:
  7. Nath A, Yewale S, Tran T, Brebbia JS, Shope TR, et al. Dysphagia after vertical sleeve gastrectomy: Evaluation of risks factors and assessment of endoscopic intervention. World J Gastroenterol. 2016; 22: 10371-10379. Ref.:
  8. Corazza GR, Menozzi MG, Strocchi A, Rasciti L, Vaira D, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990; 98: 302-309. Ref.:
  9. Malathi P, Preiser H. Isolation of the sodium-dependent d-glucose transport protein from brush-border membranes. Biochim Biophys Acta. 1983; 735: 314-324. Ref.:
  10. Hamilton KL, Butt AG. Glucose transport into everted sacs of the small intestine of mice. Adv Physiol Educ. 2013; 37: 415-426. Ref.:
  11. Thorens B. Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter. Int Rev Cytol. 1992; 137: 209-238. Ref.:
  12. Rashti F, Gupta E, Ebrahimi S, Shope TR, Koch TR, et al. Development of minimally invasive techniques for management of medically-complicated obesity. World J Gastroenterol. 2014; 20: 13424-13445. Ref.:
  13. Yamamoto H, Kaida S, Yamaguchi T, Murata S, Tani M, et al. Potential mechanisms mediating improved glycemic control after bariatric/metabolic surgery. Surg Today. 2016; 46: 268-274. Ref.:
  14. Lin EC, Massey BT. Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth. Clin Gastroenterol Hepatol. 2016; 14: 203-208. Ref.:
  15. Trung VN, Yamamoto H, Furukawa A, Yamaguchi T, Murata S, et al. Enhanced intestinal motility during oral glucose tolerance test after laparoscopic sleeve gastrectomy: Preliminary results using cine magnetic resonance imaging. 2013; 8: 65739. Ref.:  
  16. Melissas J, Leventi A, Klinaki I, Perisinakis K, Koukouraki S, et al. Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study. Ann Surg. 2013; 258: 976-982. Ref.:
  17. Shah S, Shah P, Todkar J, Gagner M, Sonar S, et al. Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010; 6: 152-157. Ref.: